“SonoSite’s M-Turbo(r) vital to intensive care at Royal Surrey”

666
The Royal Surrey County Hospital, Guildford, relies on SonoSite’s
M-Turbo(r) point-of-care ultrasound system for diagnosis and treatment
in its intensive care unit. Dr. Justin Kirk-Bayley, consultant
intensivist and anesthetist explained: “The Royal Surrey County
Hospital is a leading general hospital and specialist tertiary center
for cancer  and hepatobiliary and oesophagogastric surgery, and our intensive care unit
supports a lot of major surgical work. We had outgrown our previous
an ultrasound system in terms of the image quality we wanted to achieve,
and upgraded to the M-Turbo so that we could broaden our range of
ultrasound capabilities, as well as having an instrument suitable for
training purposes.”
“The M-Turbo is an asset for diagnosis and treatment purposes, meeting
all our needs. We can accommodate several different probes and switch
between them at the click of a button. It also allows us to perform
echocardiography, offering the image quality that radiologists and
cardiologists are used to and eliminating the need to borrow equipment
from other departments. The easy to use interface, with its large,
clearly labeled buttons, makes the system very, very simple to learn
and remember, so the M-Turbo is also an ideal training tool. There is no
significant startup time, you can get scans up and running straight
away, and the learning curve is very shallow indeed; trainees pick
things up very quickly. The M-Turbo’s robustness is equally important,
as ITU is a fairly rigorous environment. We have had the M-Turbo since
March, and everyone loves it. The quality of the images achievable with
it is fantastic, and one almost couldn’t hope for anything better.”
For more information about SonoSite products, please contact:
Alexander House, 40A Wilbury Way, Hitchin SG4 0AP
T +44 (0)1462 444 800, F +44 (0)1462 444 801
Mail: ukresponse@sonosite.com
About SonoSite
SonoSite, Inc. (http://www.sonosite.com) is the
innovator and world leader in bedside and point-of-care ultrasound and
an industry leader in ultra high-frequency micro-ultrasound technology
and impedance cardiography equipment. Headquartered near Seattle, the
company is represented by fourteen subsidiaries and a global
distribution network in over 100 countries. SonoSite’s small,
lightweight systems are expanding the use of ultrasound across the
clinical spectrum by cost-effectively bringing high-performance
ultrasound to the point of patient care.
SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in
Hitchin, Hertfordshire, oversees a direct sales distribution network in
the UK and provides sales and marketing support for SonoSite’s European
offices.